Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Early-Career Scientific Research Grants Program

    Early-Career Scientific Research Grants Program supports early-career investigators’ original research in blood banking, transfusion medicine and biotherapies to build data and advance research independence.

    Browse similar grants
    Foundation Grants for Biomedical ResearchCancer Research Grants 2026New Research Grants This Month

    Funder: AABB Foundation

    Due Dates: December 1, 2026 (Full application, 11:59 p.m. ET)

    Funding Amounts: Up to $100,000 total for a one- or two-year project

    Summary: Seed funding supports early-career investigators’ original research in blood banking, transfusion medicine and biotherapies toward research independence.

    Key Information: Applicants must meet the 10-year early-career criteria and must never have received a substantial research grant such as an NIH R01.


    Description

    The AABB Foundation’s Early-Career Scientific Research Grants Program funds investigator-initiated original research in blood banking, transfusion medicine and biotherapies. It helps researchers progress toward independence by building preliminary data for subsequent applications for larger grants. Innovative, new projects receive priority; awards do not supplement currently funded research.

    Research areas include immunology, hematology, immunohematology, infectious diseases, biotherapies and patient blood management. Topics range from immune tolerance, stem cell transplantation and blood group genetics to transfusion-transmitted disease detection, novel cell therapies and regenerative medicine. The program also supports anemia treatment, surgical hemostasis, blood recovery and appropriate transfusion practices. Scientific merit, meaningful data and future funding potential guide selection.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.